Page last updated: 2024-10-23

baclofen and Spinocerebellar Ataxias

baclofen has been researched along with Spinocerebellar Ataxias in 4 studies

Spinocerebellar Ataxias: A group of predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. (From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57(6):531-43)

Research Excerpts

ExcerptRelevanceReference
"Spinocerebellar ataxia type 1 (SCA1) is a progressive neurodegenerative disease caused by a gene defect, leading to movement disorder such as cerebellar ataxia."1.46Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice. ( Hirai, H; Hosoi, N; Sato, Y; Shuvaev, AN; Yanagihara, D, 2017)
"Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disorder characterized by late-infantile onset spastic ataxia and other neurological features."1.37Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): typical clinical and neuroimaging features in a Brazilian family. ( Abdala, N; Abdalla, C; Abrahão, A; Barsottini, OG; Braga-Neto, P; Pedroso, JL; Rivero, RL, 2011)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bushart, DD1
Huang, H1
Man, LJ1
Morrison, LM1
Shakkottai, VG1
Berntsson, SG1
Gauffin, H1
Melberg, A1
Holtz, A1
Landtblom, AM1
Shuvaev, AN1
Hosoi, N1
Sato, Y1
Yanagihara, D1
Hirai, H1
Pedroso, JL1
Braga-Neto, P1
Abrahão, A1
Rivero, RL1
Abdalla, C1
Abdala, N1
Barsottini, OG1

Other Studies

4 other studies available for baclofen and Spinocerebellar Ataxias

ArticleYear
A Chlorzoxazone-Baclofen Combination Improves Cerebellar Impairment in Spinocerebellar Ataxia Type 1.
    Movement disorders : official journal of the Movement Disorder Society, 2021, Volume: 36, Issue:3

    Topics: Animals; Ataxin-1; Baclofen; Calcium Channels, T-Type; Cerebellum; Chlorzoxazone; Disease Models, An

2021
Inherited Ataxia and Intrathecal Baclofen for the Treatment of Spasticity and Painful Spasms.
    Stereotactic and functional neurosurgery, 2019, Volume: 97, Issue:1

    Topics: Adult; Aged; Baclofen; Female; Friedreich Ataxia; Humans; Injections, Spinal; Male; Middle Aged; Mus

2019
Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.
    The Journal of physiology, 2017, 01-01, Volume: 595, Issue:1

    Topics: Animals; Baclofen; Biomechanical Phenomena; Calcium; Cerebellum; Disease Models, Animal; Excitatory

2017
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): typical clinical and neuroimaging features in a Brazilian family.
    Arquivos de neuro-psiquiatria, 2011, Volume: 69, Issue:2B

    Topics: Adult; Amitriptyline; Baclofen; Female; Humans; Magnetic Resonance Imaging; Male; Muscle Relaxants,

2011